Unexpected effect of furosemide on radioiodine urinary excretion in patients with differentiated thyroid carcinomas treated with iodine 131

Thyroid

Volumn 19, Issue 8, 2009, Pages 843-848

  Matovic, Milovan D ^a   Jankovic, Slobodan M ^a   Jeremic, Marija ^a   Tasic, Zoran ^b   Vlajkovic, Marina ^c  

^a Medical Faculty Kragujevac   (Serbia)

^b General Hospital Cuprija   (Serbia)

^c Medical Faculty Nis   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; IODINE 131; POTASSIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXCRETION; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; MICTURITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOACTIVITY; THYROID CARCINOMA; THYROIDECTOMY; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; CARCINOMA; DIURETICS; FEMALE; FUROSEMIDE; HUMANS; IODINE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; THYROID NEOPLASMS; TIME FACTORS;

EID: 68349084404     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0400     Document Type: Article

References (35)

1. Dietlein M, Dressler J, Eschner W, Grü nwald F, Lassmann M, Leisner B, Luster M, Moser E, Reiners C, Schicha H, Schober O 2007 Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3). Nuklearmedizin 46:213-219. (Pubitemid 47612288)
2. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E 2008 Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941-1959
3. Practice Guidelines in Oncology-Thyroid Carcinoma v.2.National Comprehensive Cancer Network, Inc. 2007 Available at http://www.nccn.org/ professionals/physician- gls/PDF/thyroid.pdf. Accessed on December 15th 2008.
4. AACE/AME Task Force on Thyroid Nodules 2006 Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Thyroid nodule guidelines. Endocr Pract 12:63-102.
5. British Thyroid Association, Royal College of Physicians. In: Perros P ed. Guidelines for the management of thyroid cancer. 2nd edition Thyroid Cancer Guidelines Update Group, Royal College of Physicians 2007, pp. 18-22.
6. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Melver B, Sherman SI and Tuttle RM 2006 The American Thyroid Association Guidelines Taskforce. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 16:1-34.
7. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit J, Wiersinga W, the European Thyroid Cancer Taskforce 2006 Consensus statement. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803.
8. Society of Nuclear Medicine Procedure Guideline for Therapy of Thyroid Disease with Iodine-131(Sodium Iodide) Version 2.0 2006 Available at http://interactive.snm.org/docs/ Therapy%20of%20Thyroid%20Disease%20with%20Iodine- 131%20v2.0.pdf. Accessed on September 10th 2008.
9. Ringel MD, Ladenson PW 2004 Controversies in the followup and management of well-differentiated thyroid cancer. Endocr Relat Cancer 11:97-116. (Pubitemid 38419726)
10. Haq MS, McCready, RV, Harmer CL 2004 Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy. Nucl Med Commun 25:799-805.
11. Gheriani H 2006 Update on epidemiology classification, and management of thyroid cancer. Libyan J Med 1: 83-95.
12. Fregly MJ, McCarthy JS 1973 Effects of diuretics on renal iodide excretion by humans. Toxicol Appl Pharmacol 25: 289-298.
13. Seabold JE, Ben-Haim S, Pettit WA, Gurli NJ, Rojeski MT, Flanigan MJ, Ponto JA and Bricker JA 1993 Diureticenhanced I-131 clearance after ablation therapy for differentiated thyroid cancer. Radiology 187:839-842. (Pubitemid 23155723)
14. McCarthy JS, Fregly MJ, Nechay BR 1967 Effects of diuretics on renal iodine excretion by rats and dogs. J Pharmacol Exp Ther 158:294-304.
15. Fregly MJ 1966 Effect of thiazides on the thyroid gland of rats. Toxicol Appl Pharmacol 8:558-566.
16. Fregly MJ, Gennaro JF Jr. 1965 Effect of thiazides on metacorticoid hypertension and on thyroid activity of rats. Can J Physiol Pharmacol 43:521-530.
17. Tepmongkol S 2002 Enhancement of radioiodine uptake in hyperthyroidism with hydrochlorothiazide: a prospective randomized control study. Eur J Nucl Med Mol Imaging 29:1307-1310. (Pubitemid 44392210)
18. Russell MB, Ingbar SH 1965 The effect of acute iodide depletion on thyroid function in man. J Clin Invest 44:1117-1124.
19. Kapucu LO, Azizoglu F, Ayvaz G, Karakoc A 2003 Effects of diuretics on iodine uptake in non-toxic goiter-comparison with low-iodine diet. Eur J Nucl Med Mol Imaging 30:1270-1272. (Pubitemid 37205383)
20. Ding H, Kuang AR, Guan CT 2004 Randomized controlled trial of hydrochlorothiazide in augmenting the dose of 131I absorbed by thyroid remnant. Sichuan Da Xue Xue Bao Yi Xue Ban 35:546-548. (Pubitemid 39006150)
21. Maruca J, Santner S, Miller K, Santen RJ 1984 Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: concise communication. J Nucl Med 25:1089-1093. (Pubitemid 14020894)
22. Republic of Serbia, Ministry of Environmental Protection 2003 Statement of ionizing radiation sources usage in medicine (in Serbian). "Službeni list SRJ," br. 32/98 i 33/98- ispr., "Službeni list SCG" 1:8-9.
23. Tuttle WK III, Brown PH 2000 Applying Nuclear Regulatory Commission Guidelines to the Release of Patients Treated with Sodium Iodine-131. J Nucl Med Technol 28:275-279.
24. Venencia CD, Germanier AG, Bustos SR, Giovannini AA, Wyse EP 2002 Hospital discharge of patients with thyroid carcinoma treated with 131I. J Nucl Med 43:61-65. (Pubitemid 34101189)
25. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885.
26. Pacini F, Ladenson P, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheld H, Felbinger R, Lassmann M, Reinert C 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled Study. J Clin Endocrinol Metab 91:926-932. (Pubitemid 43357760)
27. Maxon HR, Thomas SR, Boehringer A, Drilling J, Sperling MI, Sparks JC, Chen IW 1983 Low iodine diet in I-131 ablation of thyroid remnants. Clin Nucl Med 8:123-126. (Pubitemid 13132215)
28. Hays MT 1993 Colonic excretion of iodide in normal human subjects. Thyroid 3:31-35. (Pubitemid 23134480)
29. Giebisch G, MacLeod MB, Kavaler F 1956 Renal excretion of radioiodide in the dog. Am J Physiol 187:529-535.
30. Stason WB, Cannon PJ, Heinemann HO, Laragh JH 1966 Furosemide: a clinical evaluation of its diuretic action. Circulation 34:910-920.
31. Norfray JF, Quinn JL 3rd 1974 Furosemide mediated elevations of thyroid iodide uptake in the rat. Proc Soc Exp Biol Med 145:286-288.
32. Hamburger JI 1969 Diuretic augmentation of 131-I uptake in inoperable thyroid cancer. N Engl J Med 280:1091-1094.
33. Abbott LA, Kovacic J 2008 The pharmacologic spectrum of furosemide. J Vet Emerg Crit Care 18:26-39.
34. Chasse R 1983 Diuretics, erythropoietin, and other medications used in renal failure. In: Chernow B (ed) The Pharmacologic Approach to the Critically Ill Patient. Williams & Wilkins, Baltimore, MA, pp 632-639.
35. Brater DC 1998 Diuretic therapy. N Engl J Med 339:387-395.